. . . . "Cytokine release (IL-1α, etc.)" . "Assay interference check" . "Metabolite profiling" . "Peptide depletion" . "Translocation fraction" . "ATP content" . "Anchorage-independent growth" . "DNA synthesis" . "IL-6 secretion" . "Antioxidant enzyme activity" . "DNA strand breaks" . "Differential gene expression" . "h-CLAT activation" . "Surface markers" . "IL-1β secretion" . "Ion channel activity" . "Phase II enzyme modulation" . "Cell count" . "Early apoptosis" . "Lipid peroxidation" . "CYP inhibition" . "Agglomeration in exposure media" . "Mitochondrial membrane potential" . "Clonogenic survival" . "Morphological transformation" . "Cellular uptake fraction" . "Cellular uptake mass" . "NF-κB activation" . "Protein carbonyls" . "Permeability (Papp)" . "miRNA expression" . "CYP induction" . "Complement activation" . "Metabolomic changes" . "Oxygen consumption rate" . "TUNEL positivity" . "AR activation/inhibition" . "ER stress markers" . "p62/SQSTM1 level" . "Caspase 3/7 activity" . "IL-8 secretion" . "Proliferation index" . "Subcellular localisation" . "Heat shock proteins" . "GSH/GSSG ratio" . "Gene mutation frequency" . "TEER" . "Histone modification changes" . "Micronucleus frequency" . "ROS generation" . "Membrane integrity" . "Mitochondrial mass" . "LC3-II/I ratio" . "Skin model viability" . "Oxidative DNA damage" . "ERα/ERβ activation" . "RNS generation" . "TNF-α secretion" . "Necrosis" . "Neurite outgrowth" . "Steroidogenesis alteration" . "Cell viability" . "Coagulation interference" . "Dissolution rate in media" . "Network activity" . "KeratinoSens activation" . "Protein corona composition" . "Proteomic changes" . "Hemolysis" . "DNA methylation changes" . "Chromosomal aberrations" . "Apoptosis" . "γH2AX foci" . "Late apoptosis" . . "Christos Vasileiou" . "2026-03-04T10:05:53.476Z"^^ . . . . . . . . . . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEAz1OobdRASd9SftHrLhG905OXjv8DHndvyWzXRJ5EDFPankMSnHZPHK+g2qEeRWdonstt55CLrpTpWsVv9xRtTqPidXHbnWLBXX42iCB+EnZNoKqAVKF5GxkSR38S0uTTq3aeQJbw2kTpx6LMkspmuH95fgAI/lfqPWrxdlI98jIeHQ14UXZpiWmkkvPgC9GVgmwHiG1hB/NCA2fKCOxVodN44OfhAPtkWmPJ40IcGPSalI4HRqgLLI5PabdRk3PiG81cUngmQU1Xk6EapzkRJGenkOlGsC5L4ktEPO6LS9uBMLTMLQDtGtkrcwqg5HmeKv7Ili3vgr3LL8/GaBBOLQIDAQAB" . "VGAczk0/d8ZRGO7A18SA8eQepxpBXfVq8/7rFANmPf5K6H46SNQ1vzzfTju5T/9av9r3m6S9pLNhOSRhSoZnVceizDk9Bh2yL6kdtjrN7j76ib9bp0tY4wDT4XMY+kJO5tAKUvA8nidE7JWQS6svdumVBliKx7eMzkYjrG0Mxym50R7W6XQNdXXtWye4KFsN9SBHv2GmiUd+ruhjBxFOSMlhrfabcFazZoBJb6ySpdL6V484sIGA67J8ECb8/MmX0I5dG5kDj0zV4i0fA/X1OswhTjQ9K68Ooy/YHOjxcsSgTKpdma23OiRNiEssjErbWrBPi5BaNqzzyVykDgLYog==" . . .